Literature DB >> 6125749

Diphosphonates and inhibition of bone mineralization.

C Nagant de Deuxchaisnes, C Rombouts-Lindemans, J P Huaux, J P Devogelaer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6125749     DOI： 10.1016/s0140-6736(82)90681-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases.

Authors:  C J Rosen; C R Kessenich
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

2.  Effective short term treatment of Paget's disease with oral etidronate.

Authors:  C J Preston; A J Yates; M N Beneton; R G Russell; R E Gray; R Smith; J A Kanis
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-11

3.  Monitoring the treatment of Paget's disease with etidronate.

Authors:  J A Kanis
Journal:  Calcif Tissue Int       Date:  1984-12       Impact factor: 4.333

4.  [Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].

Authors:  S H Scharla; A Grauer; R Ziegler
Journal:  Klin Wochenschr       Date:  1991-01-04

5.  Osteopenia in cerebral palsy.

Authors:  N J Shaw; C P White; W D Fraser; L Rosenbloom
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.